Nature Communications (Aug 2023)
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
- Lukas John,
- Alexandra M. Poos,
- Alexander Brobeil,
- Carolina Schinke,
- Stefanie Huhn,
- Nina Prokoph,
- Raphael Lutz,
- Barbara Wagner,
- Maurizio Zangari,
- Stephan M. Tirier,
- Jan-Philipp Mallm,
- Sabrina Schumacher,
- Dominik Vonficht,
- Llorenç Solé-Boldo,
- Sabine Quick,
- Simon Steiger,
- Moritz J. Przybilla,
- Katharina Bauer,
- Anja Baumann,
- Stefan Hemmer,
- Christoph Rehnitz,
- Christian Lückerath,
- Christos Sachpekidis,
- Gunhild Mechtersheimer,
- Uwe Haberkorn,
- Antonia Dimitrakopoulou-Strauss,
- Philipp Reichert,
- Bart Barlogie,
- Carsten Müller-Tidow,
- Hartmut Goldschmidt,
- Jens Hillengass,
- Leo Rasche,
- Simon F. Haas,
- Frits van Rhee,
- Karsten Rippe,
- Marc S. Raab,
- Sandra Sauer,
- Niels Weinhold
Affiliations
- Lukas John
- Department of Internal Medicine V, Heidelberg University Hospital
- Alexandra M. Poos
- Department of Internal Medicine V, Heidelberg University Hospital
- Alexander Brobeil
- Department of Pathology, Heidelberg University Hospital
- Carolina Schinke
- Myeloma Center, University of Arkansas for Medical Sciences
- Stefanie Huhn
- Department of Internal Medicine V, Heidelberg University Hospital
- Nina Prokoph
- Department of Internal Medicine V, Heidelberg University Hospital
- Raphael Lutz
- Department of Internal Medicine V, Heidelberg University Hospital
- Barbara Wagner
- Department of Internal Medicine V, Heidelberg University Hospital
- Maurizio Zangari
- Myeloma Center, University of Arkansas for Medical Sciences
- Stephan M. Tirier
- Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
- Jan-Philipp Mallm
- Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant
- Sabrina Schumacher
- Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
- Dominik Vonficht
- Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
- Llorenç Solé-Boldo
- Institute of Health (BIH) at Charité—Universitätsmedizin Berlin
- Sabine Quick
- Department of Internal Medicine V, Heidelberg University Hospital
- Simon Steiger
- Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
- Moritz J. Przybilla
- Division Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ)
- Katharina Bauer
- Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant
- Anja Baumann
- Department of Internal Medicine V, Heidelberg University Hospital
- Stefan Hemmer
- Department of Orthopedic Surgery, Heidelberg University Hospital
- Christoph Rehnitz
- Department of Radiology, Heidelberg University Hospital
- Christian Lückerath
- Department of Radiology, Heidelberg University Hospital
- Christos Sachpekidis
- Department of Nuclear Medicine, University Hospital Heidelberg
- Gunhild Mechtersheimer
- Department of Pathology, Heidelberg University Hospital
- Uwe Haberkorn
- Department of Nuclear Medicine, University Hospital Heidelberg
- Antonia Dimitrakopoulou-Strauss
- Department of Nuclear Medicine, University Hospital Heidelberg
- Philipp Reichert
- Department of Internal Medicine V, Heidelberg University Hospital
- Bart Barlogie
- Myeloma Center, University of Arkansas for Medical Sciences
- Carsten Müller-Tidow
- Department of Internal Medicine V, Heidelberg University Hospital
- Hartmut Goldschmidt
- Department of Internal Medicine V, Heidelberg University Hospital
- Jens Hillengass
- Department of Medicine, Roswell Park Comprehensive Cancer Center
- Leo Rasche
- Myeloma Center, University of Arkansas for Medical Sciences
- Simon F. Haas
- Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
- Frits van Rhee
- Myeloma Center, University of Arkansas for Medical Sciences
- Karsten Rippe
- Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
- Marc S. Raab
- Department of Internal Medicine V, Heidelberg University Hospital
- Sandra Sauer
- Department of Internal Medicine V, Heidelberg University Hospital
- Niels Weinhold
- Department of Internal Medicine V, Heidelberg University Hospital
- DOI
- https://doi.org/10.1038/s41467-023-40584-4
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 17
Abstract
Abstract In multiple myeloma spatial differences in the subclonal architecture, molecular signatures and composition of the microenvironment remain poorly characterized. To address this shortcoming, we perform multi-region sequencing on paired random bone marrow and focal lesion samples from 17 newly diagnosed patients. Using single-cell RNA- and ATAC-seq we find a median of 6 tumor subclones per patient and unique subclones in focal lesions. Genetically identical subclones display different levels of spatial transcriptional plasticity, including nearly identical profiles and pronounced heterogeneity at different sites, which can include differential expression of immunotherapy targets, such as CD20 and CD38. Macrophages are significantly depleted in the microenvironment of focal lesions. We observe proportional changes in the T-cell repertoire but no site-specific expansion of T-cell clones in intramedullary lesions. In conclusion, our results demonstrate the relevance of considering spatial heterogeneity in multiple myeloma with potential implications for models of cell-cell interactions and disease progression.